Richard Sampliner

Arizona Health Sciences Center, University of Arizona, USA

Richard E Sampliner, MD

Academic positions: - Professor of Medicine at the University of Arizona - Chief of Gastroenterology at the Southern Arizona VA Health Care System - Gastroenterology Fellowship Program Director

All industry positions (in last five years): Research interests: Use biologic markers to identify subgroup of patients with Barrett's esophagus at high risk of developing adenocarcinoma; document reversal of Barrett's; colon cancer prevention study on the effects of wheat bran fiber

Any other information: Dr Sampliner is a member of the American College of Gastroenterology and the American College of Physicians. He also serves on the Training and Education Committee of the ACG and MKSAP 11 and 12 Gastroenterology and Hepatology. He received the Distinguished Clinician Award, American Gastroenterological Association, 2004.

Any competing interests declared are displayed with individual evaluations.

: Gastroenterology & Hepatology > Esophagus (15 November 2005 - 16 December 2009)

Links

http://www.azcc.arizona.edu/profile/richard-sampliner

All recent recommendations

• 6.0
  Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics.
  Recommended by Richard Sampliner with Anis Hanna
  
• 6.5
  Properties of the neosquamous epithelium after radiofrequency ablation of Barrett's esophagus containing neoplasia.
  Recommended by Krish Ragunath with Jayan Mannath, Richard Sampliner, Waqar Qureshi
  
• 6.0
  Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.
  Recommended by Richard Sampliner
  
• 6.0
  Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice.
  Recommended by Richard Sampliner
  
• 3.0
  Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study.
  Recommended by Richard Sampliner
  
• 6.5
  Systematic four-quadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy.
  Recommended by Richard Hardwick, Prateek Sharma with Ajay Bansal, Richard Sampliner
  
• 8.0
  Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults.
  Recommended by Richard Sampliner, John Inadomi with Ma Somsouk
  
• 3.0
  Predictors of medication adherence in inflammatory bowel disease.
  Recommended by Richard Sampliner
  
• 3.0
  Nocturnal reflux episodes following the administration of a standardized meal. Does timing matter?
  Recommended by Richard Sampliner
  
• 3.0
  Use of alarm symptoms to select dyspeptics for endoscopy causes patients with curable esophagogastric cancer to be overlooked.
  Recommended by Richard Sampliner
  
• 3.0
  Low-grade dysplasia in Barrett's esophagus has a high risk of progression.
  Recommended by Richard Sampliner
  
• 6.0
  Appropriateness of upper-GI endoscopy: an Italian survey on behalf of the Italian Society of Digestive Endoscopy.
  Recommended by Richard Sampliner
  
• 6.0
  NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma.
  Recommended by Richard Sampliner
  
• 6.0
  Cyclin A immunocytology as a risk stratification tool for Barrett's esophagus surveillance.
  Recommended by Richard Sampliner
  
• 3.0
  Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer).
  Recommended by Richard Sampliner
  
• 3.0
  Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence.
  Recommended by Richard Sampliner
  
• 4.8
  Prevalence of Barrett's esophagus in the general population: an endoscopic study.
  Recommended by Richard Sampliner, David Peura